HTG Molecular Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	3	12.21	9.6	22.4	7.62	8.43
Short-Term Investments	3.57	-	12.34	6.3	25.41	22.68
Cash & Short-Term Investments	6.56	12.21	21.94	28.7	33.03	31.11
Cash Growth	-69.56%	-44.35%	-23.53%	-13.12%	6.16%	212.12%
Receivables	1.13	1.42	2.09	1.59	3.16	5.01
Inventory	0.65	0.91	1.99	1.49	1.27	1.31
Prepaid Expenses	0.84	0.71	0.76	0.59	0.63	0.52
Restricted Cash	-	-	-	-	3.27	-
Other Current Assets	-	0.4	0.4	0.5	-	-
Total Current Assets	9.19	15.65	27.19	32.87	41.37	37.95
Property, Plant & Equipment	1.42	1.61	2.46	2.24	3.45	2.37
Long-Term Deferred Charges	-	-	-	-	0.15	0.07
Other Long-Term Assets	0.26	0.52	0.81	0.09	0.15	3.38
Total Assets	10.87	17.78	30.46	35.2	45.12	43.77
Accounts Payable	1.1	1.16	1.65	1.35	1.66	1.85
Accrued Expenses	1.32	2.21	2.02	1.37	1.87	3.36
Current Portion of Long-Term Debt	3.52	4.26	5.72	3.53	4.14	1.29
Current Portion of Leases	0.48	0.48	0.41	0.71	0.8	-
Current Unearned Revenue	0.1	-	-	0.19	0.43	0.33
Other Current Liabilities	0.04	0.17	0.14	0.09	-	0.19
Total Current Liabilities	6.56	8.27	9.94	7.24	8.9	7.02
Long-Term Debt	3.37	3.52	9.08	13.05	11.37	15.38
Long-Term Leases	0.42	0.55	0.95	0.42	0.71	-
Long-Term Unearned Revenue	-	-	-	0.01	0.17	0.08
Other Long-Term Liabilities	0.04	0.05	0.09	-	-	0.2
Total Liabilities	10.39	12.39	20.06	20.71	21.15	22.68
Common Stock	0	0	0	0.01	0	0.03
Additional Paid-In Capital	235.45	235.31	218.73	205.66	194.29	172.09
Retained Earnings	-234.98	-229.93	-208.33	-191.19	-170.32	-151.02
Comprehensive Income & Other	0	0	0	0.01	-0	-0
Total Common Equity	0.47	5.39	10.4	14.48	23.97	21.09
Shareholders' Equity	0.47	5.39	10.4	14.48	23.97	21.09
Total Liabilities & Equity	10.87	17.78	30.46	35.2	45.12	43.77
Total Debt	7.8	8.8	16.16	17.71	17.02	16.67
Net Cash (Debt)	-1.23	3.41	5.78	10.99	16.01	14.44
Net Cash Growth	-	-41.02%	-47.36%	-31.37%	10.88%	-
Net Cash Per Share	-0.97	3.84	10.01	25.36	75.65	94.45
Filing Date Shares Outstanding	2.21	2.21	0.63	0.52	0.32	0.16
Total Common Shares Outstanding	2.21	2.21	0.63	0.43	0.32	0.16
Working Capital	2.63	7.38	17.24	25.63	32.47	30.93
Book Value Per Share	0.21	2.44	16.45	33.43	74.27	132.81
Tangible Book Value	0.47	5.39	10.4	14.48	23.97	21.09
Tangible Book Value Per Share	0.21	2.44	16.45	33.43	74.27	132.81
Machinery	4.82	4.86	5.87	5.96	5.71	4.67
Construction In Progress	-	-	-	-	-	0.02
Leasehold Improvements	1.94	1.94	1.93	1.94	1.99	1.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.